Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical (LFCR) Long-Term Debt Issuances: 2014-2024

  • Lifecore Biomedical's Long-Term Debt Issuances was N/A to $31.8 million in Q3 2024 from the same period last year, while for Aug 2024 it was $348.0 million, marking a year-over-year change of. This contributed to the annual value of $128.6 million for FY2025, which is 14.05% down from last year.
  • Lifecore Biomedical's Long-Term Debt Issuances amounted to $31.8 million in Q3 2024, which was down 78.73% from $149.6 million recorded in Q2 2024.
  • Lifecore Biomedical's 5-year Long-Term Debt Issuances high stood at $150.0 million for Q1 2021, and its period low was $20.0 million during Q2 2021.
  • Over the past 3 years, Lifecore Biomedical's median Long-Term Debt Issuances value was $89.2 million (recorded in 2023), while the average stood at $87.0 million.
  • Data for Lifecore Biomedical's Long-Term Debt Issuances shows a peak YoY surged of 633.16% (in 2023) over the last 5 years.
  • Lifecore Biomedical's Long-Term Debt Issuances (Quarterly) stood at $20.0 million in 2021, then remained steady at $20.0 million in 2022, then surged by 633.16% to $146.6 million in 2023, then rose by 2.01% to $31.8 million in 2024.
  • Its Long-Term Debt Issuances stands at $31.8 million for Q3 2024, versus $149.6 million for Q2 2024 and $146.6 million for Q2 2023.